Plasma metabolomic study in perinatally HIV-infected children using 1H NMR spectroscopy reveals perturbed metabolites that sustain during therapy.
Urvinder Kaur SBolaji Fatai OyeyemiAnita ShetBindu Parachalil GopalanHimanshu DNeel Sarovar BhaveshRavi TandonPublished in: PloS one (2020)
Developing therapeutic strategies targeting metabolic abnormalities may be beneficial for preventing diabetes, cardiovascular disease or other associated complications in perinatally HIV-infected children.
Keyphrases
- hiv infected
- antiretroviral therapy
- cardiovascular disease
- human immunodeficiency virus
- young adults
- type diabetes
- ms ms
- stem cells
- metabolic syndrome
- adipose tissue
- cardiovascular risk factors
- mesenchymal stem cells
- cardiovascular events
- skeletal muscle
- drug delivery
- cell therapy
- smoking cessation
- replacement therapy